Navigation

Researchers at UCD

Katherine O'Reilly

Clinical Lecturer

School Of Medicine

Tel: +353 1 7166839
Email: katherine.oreilly@ucd.ie

Professional

               

Education

Year 1991 Institution:
Qualification: BSc Subject:
Year 1995 Institution:
Qualification: MD Subject:
         

Publications

Books

O'Reilly, K.M.A. and Eugene Daugherty, L. and Sime, P.J. (2004) Gender-Specific Considerations in Interstitial Lung Disease. : Elsevier Inc. [DOI] [Details]
   

Peer Reviewed Journals

Ging P, Mikulich O;O'Reilly KM (2016) 'Unexpected paracetamol (acetaminophen) hepatotoxicity at standard dosage in two older patients: time to rethink 1 g four times daily?'. Age and Ageing, . [DOI] [Details]
Loveman E, Copley VR;Colquitt J;Scott DA;Clegg A;Jones J;O'Reilly KM;Singh S;Bausewein C;Wells A (2015) 'The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluation'. Health Technology Assessment, 19 (20):1-1. [DOI] [Details]
Loveman E, Copley VR;Scott DA;Colquitt JL;Clegg AJ;O'Reilly KM (2015) 'Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis'. BMC Pulmonary Medicine, 15 . [DOI] [Details]
O'Reilly KM, Urban MA;Barriero T;Betts RF;Trawick DR (2005) 'Persistent culture-positive Legionella infection in an immunocompromised host'. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 40 (10):1-9. [DOI] [Details]
 

Conference Publications

Byrne, A., Li, L., Gantier, M., Buckley, A., O'Reilly, K., Donnelly, S.C. Baugh, J.A.; (2006) Macrophage Migration Inhibitory Factor (MIF): A Hypoxia Regulated Mediator of Pulmonary Fibrosis Hypoxia and Development, Physiology and Disease (Keystone) [Details]
Li, L., Byrne, A., O'Reilly, K.M.A., Donnelly S.C. Baugh, J.A.; (2006) Macrophage Migration Inhibitory Factory (MFI) is an early growth response-1 (EGR-1) target gene in TGFb activated human lung fibroblasts American Thoracic Society [Details]